60 Degrees Pharmaceuticals (SXTP) Accumulated Depreciation & Amortization (2022 - 2025)
60 Degrees Pharmaceuticals (SXTP) has disclosed Accumulated Depreciation & Amortization for 4 consecutive years, with $28155.0 as the latest value for Q3 2025.
- On a quarterly basis, Accumulated Depreciation & Amortization rose 549.63% to $28155.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $28155.0, a 549.63% increase, with the full-year FY2024 number at $11726.0, down 44.59% from a year prior.
- Accumulated Depreciation & Amortization was $28155.0 for Q3 2025 at 60 Degrees Pharmaceuticals, up from $9236.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $146189.0 in Q3 2023 to a low of $407.0 in Q1 2024.
- A 4-year average of $45222.9 and a median of $11726.0 in 2024 define the central range for Accumulated Depreciation & Amortization.
- Peak YoY movement for Accumulated Depreciation & Amortization: crashed 98.62% in 2024, then soared 1544.72% in 2025.
- 60 Degrees Pharmaceuticals' Accumulated Depreciation & Amortization stood at $126902.0 in 2022, then crashed by 83.32% to $21162.0 in 2023, then tumbled by 44.59% to $11726.0 in 2024, then skyrocketed by 140.11% to $28155.0 in 2025.
- Per Business Quant, the three most recent readings for SXTP's Accumulated Depreciation & Amortization are $28155.0 (Q3 2025), $9236.0 (Q2 2025), and $6694.0 (Q1 2025).